Learn more about ongoing research projects
ResearchGate Google Scholar Addgene AcademicTree Lytos Technologies
Biochemical Engineering Journal
SynBio
Frontiers in Synthetic Biology

Biomineralization
We are developing the enzyme silicatein as a model system for production of metal oxide nanoparticles (as shown to the left), as well as investigating new microbial- and enzyme-based systems to produce advanced, functional inorganic materials such as lithium hydroxide nanoparticles.
Biosurfactants
We are developing protein-based biosurfactants such as hydrophobin (see figure to the right) as alternatives to chemical surfactants, with applications in drug delivery and formulation as well as biomass conversion to recover crystalline nanocellulose. We work closely with colleagues at UC Davis to inform both design and applications.


Bioremediation
We are developing protein-based tools to detect and remove PFAS from soil, water and foods, and investigating use of hemp (as shown on the left) and other plants as phytoremediation tools.
Transmembrane signaling
In collaboration with colleagues at UMD, we are investigating interactions between SARS-CoV2 accessory proteins and host proteins involved in immune recognition, and developing tools and techniques to characterize receptor heterodimerization.


Antimicrobials
We have identified and engineered polysaccharide-degrading enzymes as tools to remove microbial biofilm and inhibit pathogenic bacterial/fungal growth (as shown on the left). Additionally, we have commercialized enzymes developed in lab for applications in pre- and post-harvest agriculture, and collaborate with other partners such as the USDA for applications in food safety, VT for blight removal, KSU for anti-fungals and UVA BME, UMD and NISER for multi-drug resistant bacterial infection.
Industrial hemp
In collaboration with external industrial partners such as Air Products, USDA and SUNY we are evaluating the use of cryogenic technologies to improve fiber (shown in the figure on the right), flower and seed processing for commercial applications. Additionally, in collaboration with Trulieve we are investigating new therapeutic applications of minor cannabinoids as well as improved processing and formulation methods for a wide range of consumer products.
